The effectiveness means shares can be priced and sold as soon as the next business day. Expect heavy selling pressure as the company raises distressed capital with no minimum — the offering could close at any size, creating asymmetric downside risk. Monitor for pricing announcement and subsequent dilution overhang.
Price Chart
Executive Summary
iSpecimen's S-1 registration statement (File No. 333-297001) became effective on July 30, 2026, enabling the company to proceed with a best-efforts offering of up to 1,544,402 shares of common stock and pre-funded warrants at an assumed price of $2.59 per share. This follows a prior S-1/A that increased the maximum offering to $5M, and the company has a going concern opinion with a 79% YoY revenue decline to $1.9M in FY2025. The effectiveness unlocks immediate dilution of up to ~167% of the current $3M market cap, making this a distressed capital raise with no minimum offering requirement.
Key Facts
- S-1 registration (File No. 333-297001) declared effective on July 30, 2026
- Offering up to 1,544,402 shares of common stock and pre-funded warrants on a best-efforts basis with no minimum
- Assumed public offering price of $2.59 per share (closing price on June 18, 2026)
- Prior S-1/A increased maximum offering from $4M to $5M (up to 2,092,050 shares at $2.39/sh)
- Company has a going concern opinion, negative working capital, and 79% YoY revenue decline in FY2025 to $1.9M
- Offering is highly dilutive at ~167% of the current $3M market cap
- E.F. Hutton engaged as exclusive placement agent with 4% cash fee plus 1% non-accountable expense allowance
- No minimum offering amount required as condition to closing
Financial Impact
Up to $5M gross proceeds from offering of up to 2,092,050 shares at $2.39/sh (per S-1/A), representing ~167% dilution of current $3M market cap
Risk Factors
- Extreme dilution of ~167% of current market cap
- No minimum offering amount — proceeds could be far below maximum
- Going concern risk with 79% YoY revenue decline and negative working capital
- Best-efforts offering may fail to raise sufficient capital, worsening liquidity crisis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002496 |
| Document: 9999999995-26-002496-index.html | 9999999995-26-002496 |
| Document: 9999999995-26-002496.txt | 9999999995-26-002496 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $1.47 | awaiting T+60 | — | $0.8400 (+42.86%) |
Sep 4, 2026 7w ago | 8-K | $1.59 | awaiting T+60 | — | $0.8400 (−47.17%) |
Aug 14, 2026 10w ago | 8-K | $2.15 | awaiting T+60 | — | $0.8400 (+60.93%) |
Aug 7, 2026 11w ago | 8-K | $2.24 | awaiting T+60 | — | $0.8400 (+62.50%) |
Aug 7, 2026 11w ago | 424B4 | $2.22 | awaiting T+60 | — | $0.8400 (+62.16%) |
Jul 31, 2026 12w ago | EFFECT | $1.89 $0.8398 | ▲ +55.57% | ▲ +58.02% | $0.8400 (+55.56%) |
Jul 16, 2026 14w ago | S-1/A | $2.10 $1.08 | ▲ +48.57% | ▲ +53.25% | $0.8400 (+60.00%) |
Jul 14, 2026 14w ago | 8-K | $2.23 $1.09 | ▼ −51.12% | ▼ −53.65% | $0.8400 (−62.33%) |
Jun 18, 2026 18w ago | EFFECT | $2.59 $1.47 | ▲ +43.24% | ▲ +45.14% | $0.8400 (+67.57%) |
Jun 1, 2026 21w ago | 8-K | $3.07 $1.64 | ▲ +46.58% | ▲ +47.70% | $0.8400 (+72.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers